NewAmsterdam Pharma Co N.V. (NAMS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NAMS currently has 119M outstanding shares. with moderate dilution risk from 33.5M authorized shares representing 28.2% potential dilution. The company has significantly diluted shareholders by 33.03% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 05, 2025 |
10-Q filing | 119.0M shares outstanding |
120M | 34M |
| Aug 06, 2025 |
10-Q filing | 118.6M shares outstanding |
120M | 34M |
| May 08, 2025 |
10-Q filing | 116.1M shares outstanding |
120M | 34M |
| Feb 28, 2025 |
S-3 filing: The company intends to offer and sell, from time to time, up to $500 million of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and/or units. |
110M | 34M |
| Feb 26, 2025 |
10-K filing | 109.8M shares outstanding |
110M | 21M |
| Nov 06, 2024 |
10-Q filing | 94.8M shares outstanding |
95M | 21M |
| Aug 09, 2024 |
POS AM filing: This is a Post-Effective Amendment to terminate the effectiveness of a registration statement and deregister all unsold securities. |
95M | 21M |
| Aug 07, 2024 |
10-Q filing | 94.7M shares outstanding |
95M | 21M |
| Jul 03, 2024 |
S-3 filing: The company is filing an S-3 to offer and sell up to $400 million of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and/or units from time to time. |
88M | 21M |
| May 08, 2024 |
10-Q filing | 88.4M shares outstanding |
88M | 0 |
| Apr 12, 2024 |
POS AM filing: This POS AM filing describes the potential offering of up to $400 million of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and/or units, and specifies an ATM offering of ordinary shares up to $150 million through TD Cowen. |
82M | 0 |
| Feb 28, 2024 |
10-K filing | 82.2M shares outstanding |
82M | 41M |
| Feb 28, 2024 |
POS AM filing: This POS AM filing includes information on the offering of Ordinary Shares underlying Rollover Options, Ordinary Shares issuable upon exercise of warrants, Earnout Shares, and Ordinary Shares offered for re-sale by Selling Securityholders. |
89M | 41M |
| Dec 07, 2023 |
F-3 filing: The company is filing an F-3 to register an offering of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and/or units up to an aggregate of $400,000,000. |
82M | 41M |
| Aug 07, 2023 |
POS AM filing: This is a POS AM filing to register (i) issuance of Ordinary Shares underlying Rollover Options, Ordinary Shares issuable upon exercise of Warrants, and Earnout Shares and (ii) offer and sale from time to time of Ordinary Shares and Private Placement Warrants by the Selling Securityholders. |
82M | 0 |
| Apr 17, 2023 |
POS AM filing: This POS AM filing includes information on ordinary shares offered by the company, ordinary shares offered for re-sale by selling securityholders, warrants offered by selling securityholders, and ordinary shares outstanding. |
82M | 0 |
| Mar 31, 2023 |
20-F filing | 81.6M shares outstanding |
82M | 79M |
| Dec 20, 2022 |
F-1 filing: This F-1 filing includes information on the offering of Ordinary Shares by the company and Ordinary Shares and Warrants offered for re-sale by Selling Securityholders. |
82M | 79M |